{"id":"https://openalex.org/W1967229252","doi":"https://doi.org/10.1182/blood-2003-11-3896","title":"After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies","display_name":"After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies","publication_year":2004,"publication_date":"2004-09-10","ids":{"openalex":"https://openalex.org/W1967229252","doi":"https://doi.org/10.1182/blood-2003-11-3896","mag":"1967229252","pmid":"https://pubmed.ncbi.nlm.nih.gov/15358622"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2003-11-3896","doi":"https://doi.org/10.1182/blood-2003-11-3896","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2003-11-3896","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047939331","display_name":"Martha Wadleigh","orcid":"https://orcid.org/0000-0002-8191-1708","observed_orcids":["https://orcid.org/0000-0002-8191-1708"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Wadleigh","raw_affiliation_strings":["From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039503690","display_name":"James D. Griffin","orcid":"https://orcid.org/0000-0003-1823-7930","observed_orcids":["https://orcid.org/0000-0003-1823-7930"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D. Griffin","raw_affiliation_strings":["From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Leukemia Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.6788,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.83577713,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"105","issue":"1","first_page":"22","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0478999987244606,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.04340000078082085,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tyrosine-kinase","display_name":"tyrosine kinase","score":0.8999999761581421},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9629999995231628},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9509999752044678},{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.6600000262260437},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.7369999885559082},{"id":"https://openalex.org/keywords/signal-transduction","display_name":"signal transduction","score":0.6069999933242798},{"id":"https://openalex.org/keywords/kinase-mutations","display_name":"kinase mutations","score":0.5070000290870667},{"id":"https://openalex.org/keywords/kinase-overexpression","display_name":"kinase overexpression","score":0.7070000171661377},{"id":"https://openalex.org/keywords/leukemogenesis","display_name":"leukemogenesis","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.7714179754257202},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.7021933197975159},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6863131523132324},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5478730201721191},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5394888520240784},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5251491069793701},{"id":"https://openalex.org/C85528070","wikidata":"https://www.wikidata.org/wiki/Q643602","display_name":"Protein tyrosine phosphatase","level":3,"score":0.47554823756217957},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.43783241510391235},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4359903931617737},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3870197534561157},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35623711347579956},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.16578084230422974}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2003-11-3896","doi":"https://doi.org/10.1182/blood-2003-11-3896","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2003-11-3896","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:15358622","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15358622","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":137,"referenced_works":["https://openalex.org/W8429919","https://openalex.org/W11751756","https://openalex.org/W69990049","https://openalex.org/W103700203","https://openalex.org/W111932728","https://openalex.org/W202131393","https://openalex.org/W203888263","https://openalex.org/W213656142","https://openalex.org/W235203032","https://openalex.org/W1495717719","https://openalex.org/W1523217489","https://openalex.org/W1527623537","https://openalex.org/W1542395305","https://openalex.org/W1564365085","https://openalex.org/W1567732942","https://openalex.org/W1575487317","https://openalex.org/W1592701464","https://openalex.org/W1604111726","https://openalex.org/W1679125225","https://openalex.org/W1947748380","https://openalex.org/W1963557114","https://openalex.org/W1963846089","https://openalex.org/W1964306758","https://openalex.org/W1965295262","https://openalex.org/W1968306285","https://openalex.org/W1969855058","https://openalex.org/W1971056717","https://openalex.org/W1973882186","https://openalex.org/W1977394892","https://openalex.org/W1980914876","https://openalex.org/W1981709629","https://openalex.org/W1983999811","https://openalex.org/W1985349116","https://openalex.org/W1986559037","https://openalex.org/W1989512056","https://openalex.org/W1990030298","https://openalex.org/W1994171871","https://openalex.org/W1998593414","https://openalex.org/W1999614615","https://openalex.org/W2000998080","https://openalex.org/W2005756814","https://openalex.org/W2011474502","https://openalex.org/W2012952884","https://openalex.org/W2014082408","https://openalex.org/W2015330670","https://openalex.org/W2015616444","https://openalex.org/W2016054701","https://openalex.org/W2019906902","https://openalex.org/W2019952415","https://openalex.org/W2023256994","https://openalex.org/W2026389791","https://openalex.org/W2028904752","https://openalex.org/W2028959752","https://openalex.org/W2036011153","https://openalex.org/W2036180570","https://openalex.org/W2037099240","https://openalex.org/W2038586807","https://openalex.org/W2038596108","https://openalex.org/W2039049403","https://openalex.org/W2040322688","https://openalex.org/W2040521097","https://openalex.org/W2042382807","https://openalex.org/W2042603596","https://openalex.org/W2043696829","https://openalex.org/W2044697187","https://openalex.org/W2044761914","https://openalex.org/W2046259235","https://openalex.org/W2046516822","https://openalex.org/W2053314612","https://openalex.org/W2064698668","https://openalex.org/W2069057374","https://openalex.org/W2074740152","https://openalex.org/W2078481381","https://openalex.org/W2082408605","https://openalex.org/W2084329775","https://openalex.org/W2086404440","https://openalex.org/W2086626683","https://openalex.org/W2089542617","https://openalex.org/W2092880883","https://openalex.org/W2093985675","https://openalex.org/W2094022450","https://openalex.org/W2097583774","https://openalex.org/W2097840856","https://openalex.org/W2101808949","https://openalex.org/W2101886636","https://openalex.org/W2102044600","https://openalex.org/W2102185636","https://openalex.org/W2103827225","https://openalex.org/W2104268548","https://openalex.org/W2104485296","https://openalex.org/W2105434446","https://openalex.org/W2105533439","https://openalex.org/W2110007614","https://openalex.org/W2110425570","https://openalex.org/W2111914345","https://openalex.org/W2114556798","https://openalex.org/W2117275417","https://openalex.org/W2117563665","https://openalex.org/W2118781121","https://openalex.org/W2124704116","https://openalex.org/W2125676392","https://openalex.org/W2125877707","https://openalex.org/W2129615499","https://openalex.org/W2129806364","https://openalex.org/W2130864403","https://openalex.org/W2131067167","https://openalex.org/W2132912591","https://openalex.org/W2134085362","https://openalex.org/W2140626630","https://openalex.org/W2142161829","https://openalex.org/W2142962849","https://openalex.org/W2142969636","https://openalex.org/W2149032069","https://openalex.org/W2150470057","https://openalex.org/W2151222524","https://openalex.org/W2160863198","https://openalex.org/W2163948608","https://openalex.org/W2164621617","https://openalex.org/W2165720262","https://openalex.org/W2166825418","https://openalex.org/W2171620774","https://openalex.org/W2171722798","https://openalex.org/W2183944688","https://openalex.org/W2253167439","https://openalex.org/W2276344482","https://openalex.org/W2303212700","https://openalex.org/W2312521628","https://openalex.org/W2312804644","https://openalex.org/W2314754766","https://openalex.org/W2329648702","https://openalex.org/W2331467208","https://openalex.org/W2404763614","https://openalex.org/W2410122372","https://openalex.org/W2440662239","https://openalex.org/W2616145558","https://openalex.org/W2805128291","https://openalex.org/W4246697467"],"related_works":["https://openalex.org/W2089404447","https://openalex.org/W2083188303","https://openalex.org/W2098623477","https://openalex.org/W2161577603","https://openalex.org/W4403878418","https://openalex.org/W3083384229","https://openalex.org/W1979697113","https://openalex.org/W2144564431","https://openalex.org/W2470843862","https://openalex.org/W2797623003"],"abstract_inverted_index":{"Tyrosine":[0],"kinases":[1,50,79],"phosphorylate":[2],"proteins":[3],"on":[4,77],"tyrosine":[5,49,78],"residues,":[6],"producing":[7],"a":[8,37,52],"biologic":[9],"signal":[10],"that":[11,58,80],"influences":[12],"many":[13,42],"aspects":[14],"of":[15,33,48,87,102],"cellular":[16],"function":[17],"including":[18],"cell":[19],"growth,":[20],"proliferation,":[21],"differentiation,":[22],"and":[23,44,62,67,95],"death.":[24],"Constitutive":[25],"or":[26,31],"unregulated":[27],"activity":[28],"through":[29],"mutation":[30],"overexpression":[32],"these":[34,107],"enzymes":[35],"is":[36],"common":[38],"pathologic":[39],"feature":[40],"in":[41,64,69,84],"acute":[43],"chronic":[45,92],"leukemias.":[46],"Inhibition":[47],"represents":[51],"strategy":[53],"to":[54,105],"disrupt":[55],"signaling":[56],"pathways":[57],"promote":[59],"neoplastic":[60],"growth":[61],"survival":[63],"hematologic":[65,88],"malignancies":[66],"likely":[68],"other":[70,90],"neoplasias":[71],"as":[72],"well.":[73],"This":[74],"review":[75],"focuses":[76],"have":[81],"been":[82],"implicated":[83],"the":[85,97,100],"pathogenesis":[86],"diseases":[89],"than":[91],"myelogenous":[93],"leukemia":[94],"discusses":[96],"evidence":[98],"for":[99],"use":[101],"small":[103],"molecules":[104],"target":[106],"kinases.":[108]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}